Correction to: Direct effects of doxorubicin on skeletal muscle contribute to fatigue

K. van Norren, A. van Helvoort, J.M. Agriles, S. van Tuijl, K. Arts, M. Gorselink, A. Laviano, D. Kegler, H.P. Haagsman, E.M. van der Beek

Research output: Contribution to journalComment/Letter to the editorAcademic

Abstract

Chemotherapy-induced fatigue is a multidimensional symptom. Oxidative stress has been proposed as a working mechanism for anthracycline-induced cardiotoxicity. In this study, doxorubicin (DOX) was tested on skeletal muscle function. Doxorubicin induced impaired ex vivo skeletal muscle relaxation followed in time by contraction impediment, which could be explained by DOX-induced changes in Ca(2+) responses of myotubes in vitro. The Ca(2+) responses in skeletal muscle, however, could not be explained by oxidative stress
Original languageEnglish
Pages (from-to)1014-1014
JournalBritish Journal of Cancer
Volume100
Issue number2
DOIs
Publication statusPublished - 2009

Fingerprint Dive into the research topics of 'Correction to: Direct effects of doxorubicin on skeletal muscle contribute to fatigue'. Together they form a unique fingerprint.

  • Cite this

    van Norren, K., van Helvoort, A., Agriles, J. M., van Tuijl, S., Arts, K., Gorselink, M., ... van der Beek, E. M. (2009). Correction to: Direct effects of doxorubicin on skeletal muscle contribute to fatigue. British Journal of Cancer, 100(2), 1014-1014. https://doi.org/10.1038/sj.bjc.6604992